chartexchange

TriSalus Life Sciences Reports Q3 2026 Revenue of $12.9 Million and Loss of $0. ...

GuruFocus | Nov 10, 2026 8:30 AM EST

Revenue Rose 11.3% Year-Over-Year as Gross Margin Improved, Though Net Loss Per Share Widened Relative to Analyst Expectations Related Stocks: TLSI ,

Read original article